Clinical trials
Completed Parkinsonian Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2006 | 4 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2017 | 4 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute for Neurodegenerative Disorders | 8 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 6 |
| AbbVie | 4 |
| Adamas Pharmaceuticals, Inc. | 4 |
| Novartis Pharmaceuticals | 3 |
| Oregon Health and Science University | 2 |
| Rutgers, The State University of New Jersey | 2 |
| California Pacific Medical Center Research Institute | 1 |
| Cerevel Therapeutics, LLC | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinsonian Disorders | 51 |
| Parkinson Disease | 43 |
| Movement Disorders | 15 |
| Neurodegenerative Diseases | 10 |
| Brain Diseases | 8 |
| Multiple System Atrophy | 8 |
| Supranuclear Palsy, Progressive | 8 |
| Central Nervous System Diseases | 7 |
| Dyskinesias | 7 |
| Nervous System Diseases | 7 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.